✦ LIBER ✦

ChemInform Abstract: Piperidinyl-2-phenethylamino Inhibitors of DPP-IV for the Treatment of Type 2 Diabetes.

✍ Scribed by John W. Benbow; et al. et al.

Publisher: John Wiley and Sons
Year: 2009
Weight: 13 KB
Volume: 40
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200936211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimization of 1,4-Diazepan-2-one-Conta

Optimization of 1,4-Diazepan-2-one-Containing Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type-2 Diabetes.

✍ Gui-Bai Liang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB

ChemInform Abstract: The Asymmetric Synt

ChemInform Abstract: The Asymmetric Synthesis of Sitagliptin, a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Feng Liu; Wansheng Yu; Wenhua Ou; Xiaoke Wang; Libo Ruan; Yiming Li; Xijiang Pen 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB

## Abstract Key step in the improved synthetic pathway to sitagliptin (VII), a new DPP‐IV inhibitor for the treatment of type 2 diabetes mellitus, is an asymmetric Michael addition to give intermediate (IV).

3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-ox

3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino] -3-methylbutyramide Analogues as Selective DPP-IV Inhibitors for the Treatment of Type-II Diabetes.

✍ Weir-Torn Jiaang; et al. et al. 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 24 KB

ChemInform Abstract: Sulfonylureido Thia

ChemInform Abstract: Sulfonylureido Thiazoles as Fructose-1,6-bisphosphatase Inhibitors for the Treatment of Type-2 Diabetes.

✍ Eric Kitas; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 20 KB 👁 1 views

ChemInform Abstract: Discovery of Carmeg

ChemInform Abstract: Discovery of Carmegliptin (I): A Potent and Long-Acting Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Patrizio Mattei; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 16 KB 👁 2 views

Novel therapeutic strategies for the tre

Novel therapeutic strategies for the treatment of Type 2 diabetes

✍ Perfetti, Riccardo ;Barnett, Philip S ;Mathur, Ruchi ;Egan, Josephine M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB 👁 1 views

Diabetes mellitus is the most common endocrine disease, accounting for over 200 million people affected worldwide. It is characterized by a lack of insulin secretion and/or increased cellular resistance to insulin, resulting in hyperglycemia and other metabolic disturbances. People with diabetes suf